Characteristics |
Mean [range] |
Age |
63 [19-89] |
Frequency (%) |
|
Sex |
|
Men |
549 (74%) |
Women |
190 (26%) |
Tumor location |
|
Oral cavity |
199 (27%) |
Oropharynx |
262 (35%) |
Hypopharynx |
52 (7%) |
Larynx |
205 (28%) |
Unknown primary |
21 (3%) |
Disease stadium (clinical) |
|
I |
163 (22%) |
II |
132 (18%) |
III |
127 (17%) |
IV |
317 (43%) |
Treatment |
|
Single treatment |
393 (53%) |
Surgery |
152 (39%) |
Among which CO2-laser |
47 (31%) |
Radiotherapy |
241 (61%) |
|
|
Combination treatment |
346 (47%) |
Chemoradiotherapy |
215 (62%) |
Surgery and radiotherapy |
106 (31%) |
Surgery and chemoradiotherapy |
23 (7%) |
Other combination treatment** |
2 (0.6%) |
** Other combination treatment was radiotherapy with hyperthermic treatment or
patient died before start of treatment